NDC 42571-166

Lamivudine, Nevirapine, and Zidovudine

Lamivudine, Nevirapine, And Zidovudine

Lamivudine, Nevirapine, and Zidovudine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Micro Labs Limited. The primary component is Lamivudine; Nevirapine; Zidovudine.

• Product ID: 42571-166_73d82e59-0f5b-0502-e053-2a91aa0a3f52
• NDC: 42571-166
• Product Type: Human Prescription Drug
• Proprietary Name: Lamivudine, Nevirapine, and Zidovudine
• Generic Name: Lamivudine, Nevirapine, And Zidovudine
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2018-09-03
• Marketing Category: NDA / NDA
• Application Number: NDA205626
• Labeler Name: Micro Labs Limited
• Substance Name: LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
• Active Ingredient Strength: 150 mg/1; mg/1; mg/1
• Pharm Classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 42571-166-60

60 TABLET, FILM COATED in 1 BOTTLE (42571-166-60)

• Marketing Start Date: 2018-09-03
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 42571-166-32 [42571016632]

Lamivudine, Nevirapine, and Zidovudine TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA205626
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-09-03
• Marketing End Date: 2019-12-17

NDC 42571-166-29 [42571016629]

Lamivudine, Nevirapine, and Zidovudine TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA205626
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-09-03
• Marketing End Date: 2019-12-17

NDC 42571-166-60 [42571016660]

Lamivudine, Nevirapine, and Zidovudine TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA205626
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-09-03
• Marketing End Date: 2019-12-17

Drug Details

Active Ingredients

Ingredient	Strength
LAMIVUDINE	150 mg/1

OpenFDA Data

• SPL SET ID: aae85037-761c-45f9-bcee-319710528ab7
• Manufacturer:
  • Micro Labs Limited
• UNII:
  • 2T8Q726O95
  • 99DK7FVK1H
  • 4B9XT59T7S
• RxNorm Concept Unique ID - RxCUI:
  • 687064
• UPC Code:
  • 0342571166601

Pharmacological Class

• Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Non-Nucleoside Analog [EXT]
• Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Cytochrome P450 3A Inducers [MoA]
• Cytochrome P450 2B6 Inducers [MoA]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]